Literature DB >> 15888282

Quantitative treatment of the hyponatremia of cirrhosis.

L Castello1, M Pirisi, P P Sainaghi, E Bartoli.   

Abstract

BACKGROUND: Hyponatremia represents a frequent complication of liver cirrhosis, associated with adverse events and death. It is caused either by excessive water retention or solute depletion, or a combination of both. AIMS: To determine the cause of hyponatremia clinically and to examine the usefulness of quantitative calculations of water excess and Na deficit to guide treatment.
METHODS: We studied 23 patients with liver cirrhosis and PNa < or =131 meq/L to determine the cause of hyponatremia and results of quantitative treatment.
RESULTS: The most frequent cause of hyponatremia was diuretic-induced Na depletion, which occurred in 14 out of 23 instances, while four patients had water excess. Hyponatremia was corrected after a quantitative estimate of the Na deficit or relative water excess by algebraic formulas. The former was quantitatively replenished as 3% NaCl, the latter was excreted with the technique of furosemide-induced diuresis and re-infusion of solute, but not water, losses. After quantitative replacement, there was a significant correlation (R=0.98, P< 0.001) between the Na concentration predicted mathematically and that actually measured.
CONCLUSIONS: The hyponatremia of cirrhosis is frequently caused by diuretics. Its treatment can be effectively guided with the aid of quantitative estimates of Na deficit and/or water excess in all instances, although the methods of correction described are indicated in severe clinical conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15888282     DOI: 10.1016/j.dld.2004.10.008

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  4 in total

Review 1.  Hyponatraemia in clinical practice.

Authors:  M Biswas; J S Davies
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

2.  A new method to distinguish the hyponatremia of electrolyte loss from that due to pure solvent changes.

Authors:  E Bartoli; L Castello; L Bergamasco; P P Sainaghi
Journal:  Eur J Appl Physiol       Date:  2007-06-05       Impact factor: 3.078

3.  Hypertonic saline for severe symptomatic hyponatraemia: real-world findings from the UK.

Authors:  Muhammad Fahad Arshad; Ahmed Iqbal; James Weeks; Ines Fonseca; Alia Munir; William Bennet
Journal:  Endocr Connect       Date:  2022-05-23       Impact factor: 3.221

4.  The Clinical Practice Guideline on diagnosis and treatment of hyponatraemia: a response from Otsuka Pharmaceutical Europe Ltd.

Authors:  Marco Avila
Journal:  Eur J Endocrinol       Date:  2014-07       Impact factor: 6.664

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.